RPL19P14

Across TCGA pan-cancer cohorts, RPL19P14 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPL19P14’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL19P14 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL19P14 is over-expressed in tumor.

COAD, BRCA, and LIHC are the cancer types where RPL19P14 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL19P14 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.088	.001	9	view →
BRCA	All	All	+0.099	.046	1	view →
LIHC	All	II,III,IV	+0.018	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPL19P14–COAD

Open the COAD breakdown →